Australia Non-pvc Iv Bags Market Size & Outlook, 2023-2030
Australia non-pvc iv bags market, 2018-2030 (US$M)
Related Markets
Australia non-pvc iv bags market highlights
- The Australia non-pvc iv bags market generated a revenue of USD 34.5 million in 2023 and is expected to reach USD 77.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, single chamber was the largest revenue generating product in 2023.
- Multi Chamber is the most lucrative product segment registering the fastest growth during the forecast period.
Non-pvc iv bags market data book summary
| Market revenue in 2023 | USD 34.5 million |
| Market revenue in 2030 | USD 77.9 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Single chamber |
| Fastest growing segment | Multi Chamber |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Chamber, Multi Chamber |
| Key market players worldwide | Baxter International Inc, B. Braun, Pfizer Inc, Fresenius SE & Co KGaA, Angiplast, Kraton Performance Polymers |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global non-pvc iv bags market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China non-pvc iv bags market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 181.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-PVC IV Bags Market Scope
Non-PVC IV Bags Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia non-pvc iv bags market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-pvc iv bags market will help companies and investors design strategic landscapes.
Single chamber was the largest segment with a revenue share of 60.29% in 2023. Horizon Databook has segmented the Australia non-pvc iv bags market based on single chamber, multi chamber covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing incidence of cardiovascular diseases in Australia is driving the non-PVC IV bags market in this region. For instance, as per the data reported by the Australian Institute of Health and Welfare in 2022, cardiovascular diseases contributed to nearly 12% of the overall disease burden in Australia, impacting 14% of men and 10% of women.
Moreover, as per the same source, due to various cardiovascular diseases, people in Australia faced a substantial health burden in 2022, with an estimated 670,000 years of healthy life lost. Thus, the increasing number of cardiovascular disease cases leads to the rising demand for IV therapies. This growing demand may encourage healthcare providers to look for better and safer options, possibly increasing the use of non-PVC IV bags for patients, propelling the industry growth.
Some of the companies operating in Australia non-PVC IV bags market are Baxter, B. Braun SE, Pfizer, and Fresenius Kabi Australia Pty Limited. These companies are involved in enhancing their product portfolios with launch of novel products.
Reasons to subscribe to Australia non-pvc iv bags market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia non-pvc iv bags market databook
-
Our clientele includes a mix of non-pvc iv bags market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia non-pvc iv bags market , including forecasts for subscribers. This country databook contains high-level insights into Australia non-pvc iv bags market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia non-pvc iv bags market size, by product, 2018-2030 (US$M)
Australia Non-PVC IV Bags Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
